CDTX (MKap $88 M) (Cash $54 M) Attraktive Pipeline (Seite 8)
eröffnet am 17.12.20 20:14:34 von
neuester Beitrag 04.05.24 08:50:51 von
neuester Beitrag 04.05.24 08:50:51 von
Beiträge: 560
ID: 1.336.507
ID: 1.336.507
Aufrufe heute: 9
Gesamt: 56.202
Gesamt: 56.202
Aktive User: 0
ISIN: US1717572069 · WKN: A3D4A6 · Symbol: CDTX
12,510
USD
-1,34 %
-0,170 USD
Letzter Kurs 04.05.24 Nasdaq
Neuigkeiten
26.04.24 · globenewswire  |
25.04.24 · Business Wire (engl.) |
24.04.24 · globenewswire |
24.04.24 · globenewswire |
Werte aus der Branche Biotechnologie
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 38,27 | +28,16 | |
| 8,0780 | +27,90 | |
| 10,155 | +21,04 | |
| 8,1400 | +20,41 | |
| 3,6100 | +17,51 |
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 0,6700 | -26,58 | |
| 2,1300 | -34,41 | |
| 3,1600 | -38,64 | |
| 1,7000 | -49,40 | |
| 125,00 | -95,83 |
Beitrag zu dieser Diskussion schreiben
Feedback
leider nichts neues seitens EMA
https://www.ema.europa.eu/en/news/meeting-highlights-committ…
aber gestern nach boersenschluss zu cd388
As part of a recent prioritization of its R&D business, Janssen has announced
its intention to discontinue internal development of the majority
of its infectious disease pipeline, including JNJ-0953 (CD388)
https://finance.yahoo.com/news/cidara-therapeutics-provides-…
https://www.ema.europa.eu/en/news/meeting-highlights-committ…
aber gestern nach boersenschluss zu cd388
As part of a recent prioritization of its R&D business, Janssen has announced
its intention to discontinue internal development of the majority
of its infectious disease pipeline, including JNJ-0953 (CD388)
https://finance.yahoo.com/news/cidara-therapeutics-provides-…
Antwort auf Beitrag Nr.: 74.164.829 von bonDiacomova am 17.07.23 10:15:53Committee for medicinal products for human use (CHMP)
Draft agenda for the meeting on 17-20 July 2023
heute ist donnerstag der 20.
das meeting endet heute
die Meeting highlights
werden Friday after Committee plenary veroeffentlicht - ergo morgen im laufe des tages
die veroeffentlichung (meeting highlights) des letzten meetings sahen so aus :
https://www.ema.europa.eu/en/news/meeting-highlights-committ…
hasta mañana ;-))
Draft agenda for the meeting on 17-20 July 2023
heute ist donnerstag der 20.
das meeting endet heute
die Meeting highlights
werden Friday after Committee plenary veroeffentlicht - ergo morgen im laufe des tages
die veroeffentlichung (meeting highlights) des letzten meetings sahen so aus :
https://www.ema.europa.eu/en/news/meeting-highlights-committ…
hasta mañana ;-))
rezafungin - Orphan - EMEA/H/C/005900
Mundipharma GmbH; treatment of invasive candidiasis
Scope: List of outstanding issues
Action: For adoption
List of Questions adopted on 15.12.2022.
quelle https://www.ema.europa.eu/en/documents/agenda/agenda-chmp-me…
seite 14
Mundipharma GmbH; treatment of invasive candidiasis
Scope: List of outstanding issues
Action: For adoption
List of Questions adopted on 15.12.2022.
quelle https://www.ema.europa.eu/en/documents/agenda/agenda-chmp-me…
seite 14
Cidara announced today it has joined the broad market Russell Microcap® Index
at the conclusion of the Russell U.S. Indexes annual reconstitution.
The newly reconstituted Index will become effective after
the U.S. equity market opens on Monday, June 26, 2023
quelle https://finance.yahoo.com/news/cidara-therapeutics-added-rus…
at the conclusion of the Russell U.S. Indexes annual reconstitution.
The newly reconstituted Index will become effective after
the U.S. equity market opens on Monday, June 26, 2023
quelle https://finance.yahoo.com/news/cidara-therapeutics-added-rus…
Cidara Therapeutics Added to Russell Microcap® Index
Quelle Email
Quelle Email
Trading Spotlight
Cidara Therapeutics Receives U.S. FDA Fast Track Designation
for CD388, a Novel Drug-Fc Conjugate Targeting Influenza A and B
quelle : https://finance.yahoo.com/news/cidara-therapeutics-receives-…
for CD388, a Novel Drug-Fc Conjugate Targeting Influenza A and B
quelle : https://finance.yahoo.com/news/cidara-therapeutics-receives-…
Cidara Therapeutics Receives U.S. FDA Fast Track Designation for CD388, a Novel Drug-Fc Conjugate Targeting Influenza A and B
Kam per Email
Kam per Email
B.6.3. Restart of procedure - responses received to Day 120 List of Questions timetables: for information
pdf seite 83 - Page 47/66
pdf seite 83 - Page 47/66
Antwort auf Beitrag Nr.: 73.889.230 von sauerback am 22.05.23 23:55:52koenntest Du bitte sagen auf welcher seite - vielen dank
Durchsuchen
CDTX (MKap $88 M) (Cash $54 M) Attraktive Pipeline
